The current suite supports the processing of ADVATE [Antihemophilic Factor (Recombinant
)], the company's recombinant
factor VIII (rFVIII) for the treatment of patients with hemophilia A.
It is hoped to see a sustained support and a stable environment for the biotech industry in Iran for the continued production of recombinant
protein drugs to not only meet the needs of domestic market but also find its way into the international markets in the near future.
NoV polymerase was also amplified to identify recombinant
NoV with primers Yuri22F and Yuri22R (4).
With this move, Asahi Glass will be able to increase its recombinant
protein manufacturing capacity tenfold.
Also, we are very impressed with their skills and expertise in the area of recombinant
protein development," stated Joost Holthuis, Ph.
This will allow the company to triple production of its recombinant
Factor VIII therapy.
By the end of last year, federal regulators had approved recombinant
strains of canola, potatoes, soybeans, squash, corn, and both full-sized and cherry tomatoes.
DNA products will provide great relief to patients suffering the consequences of the genetic aberrations.
Hardison assumes the role of Managing Director of Health Sciences at Recombinant
, focusing on strategic consulting and business development for life sciences companies and healthcare providers.
proteins are produced in non-transgenic plants and antibodies against those plant-produced proteins for the R&D market with the exclusive technological platform (expression vectors) and purification technologies of Creative Biomart.
Sapovirus polymerase region was also amplified to identify recombinant
sapovirus by using primers P290 and P289 (6).
Large Scale Biology Corporation (Vacaville, CA) has patented galactosidase truncated at the carboxy terminus and the production of enzymatically active recombinant
human and animal lysosomal enzymes involving construction and expression of recombinant
expression constructs comprising coding sequences of human or animal lysosomal enzymes in a plant expression system.
The Fibrogen Group also has been granted a European patent for its proprietary technology relating to the production of recombinant
Their preliminary findings suggest the clot-blocking prowess of the recombinant
version may rival that of natural hirudin.
In August 2006, ATryn([R]), GTC's recombinant
form of human antithrombin, was approved by the European Commission for use in patients with hereditary antithrombin deficiency undergoing surgical procedures.